Ablynx

Pharma

Sanofi taps Harvard spinout for oral nanobody delivery work

The partners will use i2O’s platform for protecting peptides and proteins to end the need for nanobodies to be injected.
Nick Paul Taylor Feb 16, 2021 7:35pm

Cablivi is Sanofi’s first approval from Ablynx buyout

Feb 6, 2019 12:23pm

Sanofi’s first Ablynx drug Cablivi wins EU approval

Sep 4, 2018 11:08am

Sanofi’s first product from the Ablynx deal wins CHMP backing

Jun 29, 2018 10:16am

Sanofi recruits new CFO to replace outgoing Contamine

Jun 19, 2018 10:23am

Sanofi scouts new CFO to replace retiring Jérôme Contamine

Apr 18, 2018 12:08pm